Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation
Top Cited Papers
- 1 October 2000
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 32 (4), 852-858
- https://doi.org/10.1053/jhep.2000.17924
Abstract
The natural history of clinically compensated hepatitis C virus (HCV) cirrhosis after liver transplantation is unknown. This information is relevant to transplant centers to improve the management of these patients and decide the optimal timing for retransplantation. The aims of the study were (1) to describe the natural history of patients with HCV-cirrhosis transplants in a center with annual liver biopsies, and (2) to determine predictors for clinical decompensation, retransplantation, and mortality rates. A total of 49 patients with HCV-graft cirrhosis, 39 clinically compensated at histologic diagnosis of cirrhosis (post-liver transplantation cirrhosis) were included and followed up for 1 year (15 days-3.5 years). All patients tested were infected with genotype 1b. Predictive variables included histologic activity index (HAI) at post-liver transplantation cirrhosis, liver function tests, age, sex, and maintenance immunosuppression. Eighteen of 39 patients developed at least 1 episode of decompensation after a median of 7.8 months (4 days-2.6 years; 93% ascites). The cumulative probability of decompensation was 8%, 17%, and 42% at 1, 6, and 12 months, respectively. Graft and patient survival rates were 100%, 85%, and 71% and 100%, 92%, and 74% at 1, 6, and 12 months, respectively. Patient survival rates dropped significantly once decompensation developed (93%, 61%, and 41% at 1, 6, and 12 months, respectively). Variables associated with decompensation, retransplantation, and mortality rate included a high Child-Pugh score (>A), low levels of albumin at post-liver transplantation cirrhosis, and a short interval between liver transplantation and post-liver transplantation cirrhosis. The natural history of clinically compensated HCV-graft cirrhosis is shortened when compared with immunocompetent patients. If retransplantation is considered, it should be performed promptly once decompensation develops.Keywords
This publication has 15 references indexed in Scilit:
- HCV-related fibrosis progression following liver transplantation: increase in recent yearsJournal of Hepatology, 2000
- European collaborative study on factors influencing outcome after liver transplantation for hepatitis CGastroenterology, 1999
- High Incidence of Allograft Cirrhosis in Hepatitis C Virus Genotype 1B Infection Following Transplantation: Relationship With Rejection EpisodesHepatology, 1999
- Predictors of patient and graft survival following liver transplantation for hepatitis CHepatology, 1998
- Liver transplantation in hepatitis C. A Spanish multi-centre experienceEuropean Journal of Gastroenterology & Hepatology, 1998
- Determinants of outcome of compensated hepatitis C virus-related cirrhosisHepatology, 1998
- Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patientsGastroenterology, 1997
- Long-Term Outcome of Hepatitis C Infection after Liver TransplantationNew England Journal of Medicine, 1996
- Classification of chronic hepatitis: Diagnosis, grading and stagingHepatology, 1994
- Recurrent and acquired hepatitis C viral infection in liver transplant recipientsGastroenterology, 1992